How many insider declarations has Goldman Jonathan filed?

Goldman Jonathan has filed 3 public insider declarations with SEC (Form 4).

What is Goldman Jonathan's role?

Goldman Jonathan's reported role is not specified by the regulator across the filings.

Which companies does Goldman Jonathan report trades for?

Goldman Jonathan reports trades for Avalo Therapeutics, Inc..

What is Goldman Jonathan's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 39k€.

← Executives ★ Sign in to follow

GJ

Goldman Jonathan

OFFICER

·SEC (Form 4)

Avalo Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€38,934

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Explore the detailed record of transactions filed by Goldman Jonathan. Insider active across 1 company, notably Avalo Therapeutics, Inc.. In total, 3 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €39k. History available since 14 November 2025. The latest transaction was disclosed on 14 November 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Goldman Jonathan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Avalo Therapeutics, Inc. (US)

Declarations3 total

◇

Goldman Jonathan

DirectorExecutives28 Mar 2026Avalo Therapeutics, Inc.

0SEC ↗

3,166 sharesCommon StockSEC:0002013869-26-000002:0

▼

Goldman Jonathan

DirectorExecutives14 Nov 2025Avalo Therapeutics, Inc.

$45,28819SEC ↗

3,167 shares@ US$14.30100.0% of flowCommon StockSEC:0002013869-25-000002:0

◇

Goldman Jonathan

DirectorExecutives28 Mar 2025Avalo Therapeutics, Inc.

0SEC ↗

3,167 sharesCommon StockSEC:0001578563-25-000203:0

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

GJ

Goldman Jonathan

OFFICER

·SEC (Form 4)

Avalo Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€38,934

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Explore the detailed record of transactions filed by Goldman Jonathan. Insider active across 1 company, notably Avalo Therapeutics, Inc.. In total, 3 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €39k. History available since 14 November 2025. The latest transaction was disclosed on 14 November 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.